Recent incarceration and buprenorphine maintenance treatment outcomes among human immunodeficiency virus–positive patients
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent incarceration and buprenorphine maintenance treatment outcomes among human immunodeficiency virus–positive patients
Authors
Keywords
-
Journal
Substance Abuse
Volume 38, Issue 3, Pages 297-302
Publisher
Informa UK Limited
Online
2016-08-12
DOI
10.1080/08897077.2016.1220443
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of incarceration on rates of methadone use in a community recruited cohort of injection drug users
- (2015) John D. Koehn et al. ADDICTIVE BEHAVIORS
- Impact of Illicit Drug Use on Health-Related Quality of Life in Opioid-Dependent Patients Undergoing HIV Treatment
- (2015) Brandon Aden et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial
- (2015) Josiah D Rich et al. LANCET
- A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entry
- (2014) Michael S. Gordon et al. DRUG AND ALCOHOL DEPENDENCE
- Buprenorphine Treatment for Probationers and Parolees
- (2014) Michael S. Gordon et al. Substance Abuse
- Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
- (2014) Ronald Fraser et al. Neuropsychiatric Disease and Treatment
- Retention on Buprenorphine Is Associated with High Levels of Maximal Viral Suppression among HIV-Infected Opioid Dependent Released Prisoners
- (2012) Sandra A. Springer et al. PLoS One
- Buprenorphine-Naloxone Maintenance Following Release from Jail
- (2012) Joshua D. Lee et al. Substance Abuse
- A Randomized Trial of Methadone Initiation Prior to Release from Incarceration
- (2012) Michelle McKenzie et al. Substance Abuse
- Integration of Buprenorphine/Naloxone Treatment into HIV Clinical Care: Lessons From the BHIVES Collaborative
- (2011) Linda Weiss et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- The BHIVES Collaborative: Organization and Evaluation of a Multisite Demonstration of Integrated Buprenorphine/Naloxone and HIV Treatment
- (2011) Linda Weiss et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/Naloxone
- (2011) David A Fiellin et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite Study
- (2011) Frederick L Altice et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Effect of Incarceration History on Outcomes of Primary Care Office-based Buprenorphine/Naloxone
- (2010) Emily A. Wang et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Improved HIV and Substance Abuse Treatment Outcomes for Released HIV-Infected Prisoners: The Impact of Buprenorphine Treatment
- (2010) Sandra Ann Springer et al. JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE
- Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a Nationwide Survey
- (2009) Amy Nunn et al. DRUG AND ALCOHOL DEPENDENCE
- Treating Drug Abuse and Addiction in the Criminal Justice System
- (2009) Redonna K. Chandler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- HIV/AIDS among Inmates of and Releasees from US Correctional Facilities, 2006: Declining Share of Epidemic but Persistent Public Health Opportunity
- (2009) Anne C. Spaulding et al. PLoS One
- A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release
- (2008) Michael S. Gordon et al. ADDICTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More